| Amoxicillin and Clavulanate Potassium

23:32 EDT 27th July 2015 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.
IMAGE amoxiclav-str1.jpgIMAGE amoxiclav-str2.jpg
Dose and regimen AUC0-24 (mcg•hr/mL) Cmax (mcg/mL)
amoxicillin/clavulanate potassium amoxicillin (±S.D.) clavulanate potassium (±S.D.) amoxicillin (±S.D.) clavulanate potassium (±S.D.)
* Mean values of 14 normal volunteers (n = 15 for clavulanate potassium in the low-dose regimens). Peak concentrations occurred approximately 1.5 hours after the dose.
  Administered at the start of a light meal.
   250 mg/125 mg q 8 h
26.7 ± 4.56
12.6 ± 3.25
3.3 ± 1.12
1.5 ± 0.7
  500  mg/125 mg q 12 h
33.4 ± 6.76
8.6 ± 1.95
6.5 ± 1.41
1.8 ± 0.61
500  mg/125 mg q 8 h
53.4 ± 8.87
15.7 ± 3.86
7.2 ± 2.26
2.4 ± 0.83
  875  mg/125 mg q 12 h
53.5 ± 12.31
10.2 ± 3.04
11.6 ± 2.78
2.2 ± 0.99
MIC (mcg/mL)
Interpretation
≤8/4
Susceptible (S)
16/8
Intermediate (I)
≥32/16
Resistant (R)
MIC (mcg/mL)
Interpretation
≤4/2
Susceptible (S)
≥8/4
Resistant (R)
MIC (mcg/mL)
Interpretation
≤2/1
Susceptible (S)
4/2
Intermediate (I)
≥8/4
Resistant (R)
†† Expressed as concentration of amoxicillin in the presence of clavulanic acid at a constant 2 parts amoxicillin to 1 part clavulanic acid.
Microorganism
MIC Range (mcg/mL)††
   Escherichia coli ATCC 25922
2 to 8
   Escherichia coli ATCC 35218
4 to 16
   Haemophilus influenzae ATCC 49247
2 to 16
   Staphylococcus aureus ATCC 29213
0.12 to 0.5
   Streptococcus  pneumoniae ATCC 49619
0.03 to 0.12
Zone Diameter (mm)
 Interpretation
≥18
 Susceptible  (S)
14 to 17
 Intermediate (I)
≤13
 Resistant (R)
Zone Diameter (mm)
 Interpretation
≥20
 Susceptible (S)
≤19
 Resistant (R)
 Microorganism
Zone Diameter (mm)
   Escherichia coli ATCC 25922
18 to 24
   Escherichia coli ATCC 35218
17 to 22
   Staphylococcus aureus ATCC 25923
28 to 36
   Haemophilus influenzae ATCC 49247
15 to 23

Amoxicillin and clavulanate potassium tablets may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when amoxicillin and clavulanate potassium tablets are administered at the start of a meal. To minimize the potential for gastrointestinal intolerance, amoxicillin and clavulanate potassium tablets should be taken at the start of a meal.

The number of bacteriologically evaluable patients was comparable between the 2 dosing regimens. Amoxicillin and clavulanate potassium produced comparable bacteriological success rates in patients assessed 2 to 4 days immediately following end of therapy. The bacteriologic efficacy rates were comparable at 1 of the follow-up visits (5 to 9 days post-therapy) and at a late post-therapy visit (in the majority of cases, this was 2 to 4 weeks post-therapy), as seen in the table below: 

875 mg/125 mg q 12 h 500 mg/125 mg q 8 h
   Pyelonephritis
   173 patients
   188 patients
   Complicated UTI
   135 patients
   133 patients
   Total patients
   308
   321
  875 mg/125 mg q 12 h 500 mg/125 mg q 8 h
   2 to 4 days
   81%, n = 58
   80%, n = 54
   5 to 9 days
   58.5%, n = 41
   51.9%, n = 52
   2 to 4 weeks
   52.5%, n = 101
   54.8%, n = 104

 

IMAGE amoxiclav-fig1.jpgIMAGE amoxiclav-fig2.jpgIMAGE amoxiclav-fig3.jpg

Manufacturer

NorthStar Rx LLC

Active Ingredients

Source

Clinical Trials [236 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

Clinical research study to test amoxicillin and clavulanate tablet formulation for use in Acute Bacterial Sinusitis (ABS) in adolescent patients weighing at least 40 kilogram (kg) and no m...

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions

The purpose of this study is to assess the bioequivalence between Amoxicillin/Clavulanate Potassium Oral Suspension 600/42.9 mg/5 mL and Augmentin ES-600 Oral Suspension, 600/42.9 mg/5 mL ...

A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses

The purpose of this study is to evaluate the safety and effectiveness of levofloxacin, an antibiotic, compared with amoxicillin/clavulanate potassium in the treatment of adults with rapid ...

Acupuncture and Herbal Treatment of Chronic HIV Sinusitis

To compare Traditional Chinese Medicine versus standard antibiotic therapy consisting of pseudoephedrine ( Sudafed ) plus amoxicillin / clavulanate potassium combination ( Augmentin ) in r...

Amoxicillin Clavulanate in Treatment of Acute Otitis Media

This is a prospective, randomized, double-blind, placebo controlled one-center study carried out in primary care setting of the health center of City of Turku, Finland. The study patients ...

PubMed Articles [650 Associated PubMed Articles listed on BioPortfolio]

Correction: HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity.

[This corrects the article DOI: 10.1371/journal.pone.0068111.].

Virulence and antimicrobial susceptibility of clinical and environmental strains of Aeromonas spp. from northeastern Brazil.

The aims of the present study were to isolate and identify clinical and environmental strains of Aeromonas spp. by means of biochemical tests and the automated method VITEK 2 and to investigate the pr...

Antimicrobial Effect of a Single Dose of Amoxicillin on the Oral Microbiota.

Amoxicillin is commonly used in oral surgery for antimicrobial prophylaxis against surgical-site infection and bacteremia because of its effect on oral streptococci. The aim of this study was to deter...

Interactions between Microcystis aeruginosa and coexisting amoxicillin contaminant at different phosphorus levels.

Microcystis aeruginosa was cultured with 0.05-5mgL(-1) of phosphorus and exposed to 200-500ngL(-1) of amoxicillin for seven days. Amoxicillin presented no significant effect (p>0.05) on the growth of ...

Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction.

After the implementation of pneumococcal conjugate vaccines (PCVs), the marked shift in Streptococcus pneumoniae (Pnc) serotype distribution led to a modification in pneumococcal antibiotic susceptibi...


Advertisement
 
Advertisement
 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record